首页> 外国专利> purified humanized monoclonal antibody, composition and kit for selectively inducing apoptosis in dr-4-expressing target cells, to inhibit proliferation of dr4-expressing target cells, to treat a cancer patient, to treat a patient having an inflammatory or autoimmune disease

purified humanized monoclonal antibody, composition and kit for selectively inducing apoptosis in dr-4-expressing target cells, to inhibit proliferation of dr4-expressing target cells, to treat a cancer patient, to treat a patient having an inflammatory or autoimmune disease

机译:纯化的人源化单克隆抗体,组合物和试剂盒,用于选择性地诱导表达dr-4的靶细胞凋亡,抑制表达dr4的靶细胞增殖,治疗癌症患者,治疗患有炎性或自身免疫性疾病的患者

摘要

"purified antibody that specifically binds to a dr-4 trail receptor, monoclonal antibody, composition and kit for selectively inducing apoptosis in dr-4-expressing target cells, to inhibit proliferation of dr-4-expressing target cells, to treat a cancer patient, and a patient having an inflammatory or autoimmune disease, isolated nucleic acid, vector, cultured cell, and purified polypeptide. " An antibody of the invention interacts with human dr5 or human dr4 to produce downstream receptor agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis. the nucleic acid sequences and amino acid sequences of the dr5 and dr4 antibodies were elucidated and vectors and cells containing and expressing these sequences were generated. The compositions utilizing the antibodies are detailed including compositions for treating apoptosis-related disease and treating unregulated cell development.
机译:“纯化的抗体,它特异性结合dr-4受体,单克隆抗体,组合物和试剂盒,可选择性地诱导表达dr-4的靶细胞凋亡,抑制表达dr-4的靶细胞增殖,以治疗癌症患者“本发明的抗体与人dr5或人dr4相互作用以产生下游受体激动或拮抗作用,包括抑制细胞增殖。”和凋亡。阐明了dr5和dr4抗体的核酸序列和氨基酸序列,并产生了包含和表达这些序列的载体和细胞。详细描述了利用抗体的组合物,包括用于治疗细胞凋亡相关疾病和用于治疗不受调节的细胞发育的组合物。

著录项

  • 公开/公告号BRPI0213844B1

    专利类型

  • 公开/公告日2018-12-26

    原文格式PDF

  • 申请/专利权人 UAB RESEARCH FOUNDATION;

    申请/专利号BR2002PI13844

  • 申请日2002-11-01

  • 分类号A61K39/395;C12N15/09;A61K31/337;A61K31/519;A61K31/704;A61K41;A61K45;A61K45/06;A61P3/10;A61P5/44;A61P7/06;A61P9;A61P9/10;A61P11/06;A61P13/12;A61P17;A61P21/04;A61P25/28;A61P29;A61P31/12;A61P35;A61P37;A61P37/06;A61P37/08;A61P43;C07H21/04;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/12;C12N15/63;C12P21/06;C12P21/08;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号